Stéphane De Lombaert

Title: The Innovative Contributions of Stéphane De Lombaert

Introduction

Stéphane De Lombaert is a notable inventor based in Madison, CT, with a remarkable portfolio of eight patents. His work primarily focuses on the development of small molecule inhibitors and novel compounds that have significant implications in the medical field.

Latest Patents

Among his latest patents, one notable invention is related to chymase inhibitors. These small molecule inhibitors are designed to treat various diseases and conditions involving chymase. Another significant patent involves biaryl piperazinyl-pyridine analogues, which are compounds that serve as ligands to modulate specific receptor activity in vivo or in vitro. These compounds are particularly useful in treating conditions associated with pathological receptor activation in humans, domesticated companion animals, and livestock animals. Additionally, pharmaceutical compositions and methods for utilizing these compounds to treat such disorders are provided.

Career Highlights

Stéphane has had a distinguished career, working with prominent companies such as Neurogen Corporation and Pfizer Corporation. His contributions to these organizations have been instrumental in advancing research and development in the pharmaceutical industry.

Collaborations

Throughout his career, Stéphane has collaborated with talented individuals, including Xiaozhang Zheng and Rajagopal Bakthavatchalam. These partnerships have fostered innovation and have led to significant advancements in their respective fields.

Conclusion

Stéphane De Lombaert's innovative work and contributions to the field of pharmaceuticals highlight his importance as an inventor. His patents and collaborations continue to influence the development of treatments for various medical conditions.